Read the First Edition of The Lens, a new magazine by LSI
Learn More About Asterias Biotherapeutics (NYSE: AST) (a subsidiary of BioTime; NYSE: BTX)
Asterias Biotherapeutics (NYSE: AST) (a subsidiary of BioTime; NYSE: BTX)
image
Four cell lines from which multiple therapeutic product candidates may be selected for development indications in the fields of neurology (including spinal cord injury), oncology (including autologous dendritric cells), orthopedics, and cardiovascular therapy
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next